NL Notes: Thornburg, Henderson, Medlen, Phils, Tulo

The Brewers will go the rest of the way without righties Tyler Thornburg and Jim Henderson, according to a tweet from MLB.com’s Adam McCalvy. Thornburg will receive a platelet-rich plasma injection in a bid to avoid surgery on his elbow, while Henderson may need shoulder surgery. Thornburg, 25, tossed 29 2/3 innings before being shut down, while the 31-year-old Henderson (who saved 28 games last season) scuffled through just 11 1/3 frames.

Here’s more out of the National League …

• Braves hurler Kris Medlen is just two and a half weeks away from beginning to throw again after his second Tommy John surgery, and feels confident that he’ll be back on the hill  “at some point next season,” David O’Brien of the Atlanta Journal-Constitution reports. But it remains to be seen whether he’ll work his way back with Atlanta, as his current $5.8MM salary and status as a two-time TJ patient makes him a non-tender possibility. “I’m a little nervous about it, just because it’s not in my hands,” said Medlen. “… It’s exciting to be able to pick up a ball in a couple of weeks, but I’m not going to lie, the contract stuff and wanting to come back — I mean, that’s somewhat up in the air this time, so it’s a little nerve-racking, but all I can do is get healthy.” In spite of his uncertain future, the 28-year-old righty should draw plenty of interest around the league if the Braves allow him to hit the open market.
• Were it not for Jonathan Papelbon’s continued presence at the back of the Phillies’ bullpen, young righty Ken Giles would likely have moved into the closer’s role, Ryan Lawrence of the Philadelphia Daily News writes. Commenting on the story, Buster Olney of ESPN.com (Insider link) argues that the club should move Papelbon back into a setup role to give Giles an audition as a 9th-inning option and to prevent Papelbon from finishing enough games for his 2016 option to vest at $13MM. While this approach has some facial appeal, I would note that allowing Giles to begin racking up saves now will ultimately raise his price significantly when he ultimately reaches arbitration. (And, of course, there is the question of how to handle Papelbon’s insistence that he continues to close.)
• Yesterday, Phillies GM Ruben Amaro Jr. again discussed his organization’s future, as MLB.com’s Todd Zolecki reports. Declining to give many specifics, Amaro said that the “biggest plan is to make sure we improve offensively and with our pitching overall,” saying he will look to address those (rather broadly-framed) needs “in a variety of ways.” Sitting 14 games back in the division and 11 out of the wild card, the Phillies are nonetheless not entirely ready to give up hope this year. “Right now, we’re trying to win as many games as possible,” said Amaro. “At the same time, at some point, we’re going to have to start looking to the future. … And at some point, we may be looking more at what we have to do for 2015 as far as what’s going on, on the field. … We’re not quite there yet.”
• Though Troy Tulowitzki of the Rockies continues to play shortstop at a very high level, it is time he considered moving to first base, argues Mark Kiszla of the Denver Post. Tulowitzki’s bat is obviously good enough to make the move — he led the league in all three triple-slash categories (.340/.432/.603) when he suffered his season-ending hip injury — but switching to first would obviously sap a good portion of his immense bottom-line value. On the other hand, of course, it is fair to wonder whether playing the least-demanding spot on the diamond might not only help keep Tulowitzki on the field but might also enable him to hit at a top-end level even further into the six years (and $118MM) left on his contract.